Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma
Details
Publication Year 2024,Volume 14,Issue #1,Page 137
Journal Title
Blood Cancer Journal
Publication Type
Research article
Publisher
Springer Nature
Keywords
Humans; *Multiple Myeloma/drug therapy/immunology/therapy; *Antibodies, Bispecific/therapeutic use; Female; Male; Middle Aged; Aged; Remission Induction; Antineoplastic Agents, Immunological/therapeutic use; Neoplasm Recurrence, Local/drug therapy; Adult; Treatment Outcome
Department(s)
Clinical Haematology
Open Access at Publisher's Site
https://doi.org/10.1038/s41408-024-01114-7
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-09-10 04:36:50
Last Modified: 2024-09-10 04:41:31

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙